Should an 84-year-old woman undergo bone density testing (dual-energy X‑ray absorptiometry, DEXA) and routine screening mammography?

Screening Recommendations for an 84-Year-Old Woman

DEXA Screening

An 84-year-old woman should undergo DEXA screening if she has never been screened before, as the 2025 USPSTF guidelines recommend screening all women aged 65 years and older for osteoporosis. 1

Key Considerations for DEXA at Age 84

• Initial screening is indicated if the patient has not previously undergone bone density testing, regardless of her age being 84 years. 1

• The USPSTF 2025 guidelines explicitly recommend osteoporosis screening for all postmenopausal women aged 65 years and older using DXA (dual-energy X-ray absorptiometry). 1

• If she has been previously screened, the decision to repeat DEXA depends on:

  • Her prior bone density results
  • Current fracture risk factors
  • Whether she is on treatment for osteoporosis
  • Time since last screening 1

• The evidence on optimal screening intervals remains limited, but repeat screening may be warranted if she has risk factors for accelerated bone loss or if results would change management decisions. 1

Practical Algorithm for DEXA Decision

• Never screened → Perform DEXA now 1
• Previously screened with normal BMD and no new risk factors → Consider interval screening based on fracture risk 1
• Previously screened with osteopenia or osteoporosis → Repeat DEXA to monitor disease progression or treatment response 1
• High fracture risk factors present (prior fracture, glucocorticoid use, significant weight loss) → Perform DEXA regardless of prior screening 1

---

Mammography Screening

Mammography screening should be discontinued in this 84-year-old woman unless she has excellent health status with a projected life expectancy of at least 10 years. 2

Evidence-Based Stopping Criteria

• The American College of Physicians (2019) recommends discontinuing routine mammography at age 75 years or older, with decisions guided by overall health status and expected longevity through shared decision-making. 3, 2

• The critical threshold is a life expectancy of less than 10 years, regardless of chronological age—this reflects the approximately 11-year time lag required for screening mammography to translate into mortality benefit. 2

• At age 84 with average health, projected life expectancy is typically less than 10 years, making continued screening unlikely to provide benefit. 2

Life Expectancy Assessment at Age 84

Based on modeling data for average-risk women: 2

• Age 84 with no serious comorbidities: Life expectancy approximately 8-9 years → Discontinue screening
• Age 84 with serious comorbidities (heart failure, COPD, dementia, end-stage renal disease): Life expectancy well under 10 years → Discontinue screening
• Age 84 with exceptional health: Only if truly exceptional functional status might life expectancy approach 10 years → Consider continuing only after thorough shared decision-making

Practical Algorithm for Mammography Decision

• If life expectancy < 10 years (most 84-year-olds) → Discontinue mammography 2
• If severe comorbidities present → Discontinue mammography 2
• If exceptional health with projected life expectancy ≥ 10 years → Discuss continuing screening, weighing the small absolute mortality reduction against harms (false-positives, overdiagnosis, anxiety) 3, 2

Important Caveats

• Age alone should not dictate cessation—the decision must incorporate functional status, comorbidities, and competing mortality risks. 3, 2

• The American College of Obstetricians and Gynecologists advises continuing screening until at least age 75, with individualized decisions beyond that age. 3

• Harms of continued screening include false-positive results, unnecessary biopsies, overdiagnosis of indolent cancers, and psychological distress—these harms do not diminish with age while benefits decrease. 2

• For most 84-year-old women, the balance has shifted away from benefit, and screening should be stopped. 2